Inotiv Stock Quote NOTV - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

1.555

Bid

1.46

Ask

1.54

Volume

149,580

1.40 Day's Range 1.61

1.227 52 Week Range 60.66

Market Cap

40.436M

Previous Close

1.39

Open

1.40

Last Trade

1.53

Last Trade Time

Financial Volume

$ 221,481

VWAP

1.4807

Average Volume (3m)

364,447

Shares Outstanding

26,003,960

Dividend Yield

PE Ratio

-0.39

Earnings Per Share (EPS)

-4.04

Revenue

572.43M

Net Profit

-105.14M

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. I... Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Lab Apparatus And Furniture

Website

www.inotivco.com

Headquarters

West Lafayette, Indiana, USA

Founded

2003

Inotiv Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker NOTV. The last closing price for Inotiv was $1.39. Over the last year, Inotiv shares have traded in a share price range of $ 1.227 to $ 60.66.

Inotiv currently has 26,003,960 shares outstanding. The market capitalization of Inotiv is $36.15 million. Inotiv has a price to earnings ratio (PE ratio) of -0.39.

Inotiv to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

WEST LAFAYETTE, Ind., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.029	1.9003931848	1.526	1.63	1.227	155356	1.45070735	CS
4	-0.145	-8.52941176471	1.7	2.42	1.227	183758	1.73312935	CS
12	-6.695	-81.1515151515	8.25	11.4166	1.227	364447	4.07787773	CS
26	-1.685	-52.0061728395	3.24	11.4166	1.227	324807	4.09743509	CS
52	-29.935	-95.0619244205	31.49	60.66	1.227	391666	10.32892659	CS
156	-14.275	-90.176879343	15.83	60.66	1.227	352034	10.99253347	CS
260	0	0	0	1.61	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.24M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	30.45M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	34.54M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	5.06M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	238.43M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	183.73M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	136.36M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	127.78M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	120.81M